Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShengjing Hospital
About this trial
The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.
Eligibility criteria
Qualifiers
age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography
Disqualifiers
pregnancy
reception of reperfusion treatment before admission
missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.
Trial design
Treatments tested in this trial
- no intervention
Treatment groups
No treatment groups listed
Locations
1Shengjing Hospital110004, ShenyangLiaoning, China
Sponsors and collaborators
Shengjing Hospital
Lead sponsor
Source ClinicalTrials.gov